Menu
Contact Us
Subscribe
Menu

Thank you for subscribing to our newsletter!

You will receive an email message shortly to confirm, and will need to click the link inside the email to complete your subscription. In the meantime, take a look at our recent blogs below.

Latest Posts

The European Commission’s proposal on a new EU-wide compulsory licensing regime

Olga Gurgula -
Guest author Olga Gurgula is a Senior Lecturer in Intellectual Property Law at Brunel Law School, Brunel University London A recent international health emergency, the...

The European Commission’s compulsory licensing proposals are sensible but do not go far enough

Ellen 't Hoen -
An earlier version of this comment was published in Barron's on 21 July 2023. A Spanish translation of it is also available from El...

Thanks to the European Commission, Biogen can extend Tecfidera monopoly for at least two...

Medicines Law & Policy -
According to an investigation by Follow the Money, a Dutch investigative journalism outlet, the European Commission restored the market exclusivity of Tecfidera, a multiple...

Submission to the US International Trade Commission

Ellen 't Hoen -
On 17 June 2022, World Trade Organization (WTO) Members adopted a Ministerial Decision outlining flexibilities in the WTO’s Trade Related Aspects of Intellectual Property...

The European Commission’s proposal for an EU wide compulsory licensing mechanism

Ellen 't Hoen -
In 2006 the European Generics Association was seeking clarification from the European Commission on whether generic versions of oseltamivir (Tamiflu) could be supplied to...

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

* indicates required






Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.